NTG-101: A Novel Molecular Therapy That Halts the Progression of Degenerative Disc Disease

NTG-101: A Novel Molecular Therapy That Halts the Progression of Degenerative Disc Disease In conclusion, we demonstrated that a single intra-discal injection of the novel formulation, NTG-101 confers a robust anti-inflammatory, anti-catabolic and pro-anabolic effects in pre-clinical models of DDD thereby restoring homeostasis. These findings suggest the therapeutic potential of NTG-101 for clinical use.

#science #chiropractor #chiropractic #research #education #evidence based #patient centered #interprofessional #collaborative #rehabilitation #public health #spinal health #musculoskeletal health #ethics #pain #function #disability #QOL #knowledgetranslation

Facebook Comments

Join over 12,000 Evidence-Based Chiropractors across the globe (world) in our thriving Facebook community – where knowledge, collaboration, and growth come together!

Donate

If you enjoy our content, please feel free to buy us a cup of coffee! We are grateful for your support of science-based spine care.

Research Posts

World Spine Care in Botswana

A Beginners Guide to Evidence-Based Chiropractic Clinical Practice

Research Week in Review: 21st – 26th October

Evidence based chiropractic care advances in the Philippines

Get in Touch

WE'D LOVE TO HEAR FROM YOU

© Evidence-Based Chiropractic Network All rights reserved.